Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BIRB-796 |
| Trade Name | |
| Synonyms | Doramapimod|BIRB796|BIRB 796 |
| Drug Descriptions |
Doramapimod (BIRB-796) is an oral inhibitor of P38 MAPK that enhances cytotoxicity of other anti-tumor agents (PMID: 17173546, PMID: 27082306). |
| DrugClasses | p38 MAPK Inhibitor (Pan) 3 |
| CAS Registry Number | 285983-48-4 |
| NCIT ID | C76770 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BIRB-796 | BIRB-796 | 0 | 0 |
| BIRB-796 + Dasatinib | BIRB-796 Dasatinib | 0 | 0 |
| BIRB-796 + Neratinib | BIRB-796 Neratinib | 0 | 0 |
| BIRB-796 + Tozasertib | BIRB-796 Tozasertib | 0 | 0 |